Omeros Corp (OMER) income statement
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$14.55+0.63 (+4.53%)
Close on Nov 18, 2026Market cap $1.05BP/E –Yield –
Omeros Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- 2.2%
Financial strength
- Current ratio
- 1.95
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 2.1%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?